304 related articles for article (PubMed ID: 15769989)
1. Differential expression of erythropoietin and its receptor in von hippel-lindau-associated and multiple endocrine neoplasia type 2-associated pheochromocytomas.
Vogel TW; Brouwers FM; Lubensky IA; Vortmeyer AO; Weil RJ; Walther MM; Oldfield EH; Linehan WM; Pacak K; Zhuang Z
J Clin Endocrinol Metab; 2005 Jun; 90(6):3747-51. PubMed ID: 15769989
[TBL] [Abstract][Full Text] [Related]
2. Transcriptional regulation of phenylethanolamine N-methyltransferase in pheochromocytomas from patients with von Hippel-Lindau syndrome and multiple endocrine neoplasia type 2.
Huynh TT; Pacak K; Wong DL; Linehan WM; Goldstein DS; Elkahloun AG; Munson PJ; Eisenhofer G
Ann N Y Acad Sci; 2006 Aug; 1073():241-52. PubMed ID: 17102092
[TBL] [Abstract][Full Text] [Related]
3. Chromogranin a expression in phaeochromocytomas associated with von Hippel-Lindau syndrome and multiple endocrine neoplasia type 2.
Cleary S; Phillips JK; Huynh TT; Pacak K; Fliedner S; Elkahloun AG; Munson P; Worrell RA; Eisenhofer G
Horm Metab Res; 2007 Dec; 39(12):876-83. PubMed ID: 18046660
[TBL] [Abstract][Full Text] [Related]
4. [112 cases of sporadic and genetically determined pheochromocytoma: a comparative pathologic study].
Gosset P; Lecomte-Houcke M; Duhamel A; Labat-Moleur F; Patey M; Floquet J; Viennet G; Berger-Dutrieux N; Caillou B; Franc B
Ann Pathol; 1999 Dec; 19(6):480-6. PubMed ID: 10617804
[TBL] [Abstract][Full Text] [Related]
5. Pheochromocytomas in von Hippel-Lindau syndrome and multiple endocrine neoplasia type 2 display distinct biochemical and clinical phenotypes.
Eisenhofer G; Walther MM; Huynh TT; Li ST; Bornstein SR; Vortmeyer A; Mannelli M; Goldstein DS; Linehan WM; Lenders JW; Pacak K
J Clin Endocrinol Metab; 2001 May; 86(5):1999-2008. PubMed ID: 11344198
[TBL] [Abstract][Full Text] [Related]
6. Isolated familial pheochromocytoma as a variant of von Hippel-Lindau disease.
Ritter MM; Frilling A; Crossey PA; Höppner W; Maher ER; Mulligan L; Ponder BA; Engelhardt D
J Clin Endocrinol Metab; 1996 Mar; 81(3):1035-7. PubMed ID: 8772572
[TBL] [Abstract][Full Text] [Related]
7. Pheochromocytoma in von hippel-lindau disease: distinct histopathologic phenotype compared to pheochromocytoma in multiple endocrine neoplasia type 2.
Koch CA; Mauro D; Walther MM; Linehan WM; Vortmeyer AO; Jaffe R; Pacak K; Chrousos GP; Zhuang Z; Lubensky IA
Endocr Pathol; 2002; 13(1):17-27. PubMed ID: 12114747
[TBL] [Abstract][Full Text] [Related]
8. Distinct gene expression profiles in norepinephrine- and epinephrine-producing hereditary and sporadic pheochromocytomas: activation of hypoxia-driven angiogenic pathways in von Hippel-Lindau syndrome.
Eisenhofer G; Huynh TT; Pacak K; Brouwers FM; Walther MM; Linehan WM; Munson PJ; Mannelli M; Goldstein DS; Elkahloun AG
Endocr Relat Cancer; 2004 Dec; 11(4):897-911. PubMed ID: 15613462
[TBL] [Abstract][Full Text] [Related]
9. Coexpression of erythropoietin and its receptor in endolymphatic sac tumors.
Vogel TW; Vortmeyer AO; Lubensky IA; Lee YS; Furuta M; Ikejiri B; Kim HJ; Lonser RR; Oldfield EH; Zhuang Z
J Neurosurg; 2005 Aug; 103(2):284-8. PubMed ID: 16175858
[TBL] [Abstract][Full Text] [Related]
10. Proteomic profiling of von Hippel-Lindau syndrome and multiple endocrine neoplasia type 2 pheochromocytomas reveals different expression of chromogranin B.
Brouwers FM; Gläsker S; Nave AF; Vortmeyer AO; Lubensky I; Huang S; Abu-Asab MS; Eisenhofer G; Weil RJ; Park DM; Linehan WM; Pacak K; Zhuang Z
Endocr Relat Cancer; 2007 Jun; 14(2):463-71. PubMed ID: 17639059
[TBL] [Abstract][Full Text] [Related]
11. Coexpression of erythropoietin and erythropoietin receptor in von Hippel-Lindau disease-associated renal cysts and renal cell carcinoma.
Lee YS; Vortmeyer AO; Lubensky IA; Vogel TW; Ikejiri B; Ferlicot S; Benoît G; Giraud S; Oldfield EH; Linehan WM; Teh BT; Richard S; Zhuang Z
Clin Cancer Res; 2005 Feb; 11(3):1059-64. PubMed ID: 15709172
[TBL] [Abstract][Full Text] [Related]
12. Differential genetic alterations in von Hippel-Lindau syndrome-associated and sporadic pheochromocytomas.
Bender BU; Gutsche M; Gläsker S; Müller B; Kirste G; Eng C; Neumann HP
J Clin Endocrinol Metab; 2000 Dec; 85(12):4568-74. PubMed ID: 11134110
[TBL] [Abstract][Full Text] [Related]
13. Consequences of direct genetic testing for germline mutations in the clinical management of families with multiple endocrine neoplasia, type II.
Neumann HP; Eng C; Mulligan LM; Glavac D; Zäuner I; Ponder BA; Crossey PA; Maher ER; Brauch H
JAMA; 1995 Oct; 274(14):1149-51. PubMed ID: 7563486
[TBL] [Abstract][Full Text] [Related]
14. Pheochromocytomas, multiple endocrine neoplasia type 2, and von Hippel-Lindau disease.
Neumann HP; Berger DP; Sigmund G; Blum U; Schmidt D; Parmer RJ; Volk B; Kirste G
N Engl J Med; 1993 Nov; 329(21):1531-8. PubMed ID: 8105382
[TBL] [Abstract][Full Text] [Related]
15. Perioperative outcomes of syndromic paraganglioma and pheochromocytoma resection in patients with von Hippel-Lindau disease, multiple endocrine neoplasia type 2, or neurofibromatosis type 1.
Butz JJ; Yan Q; McKenzie TJ; Weingarten TN; Cavalcante AN; Bancos I; Young WF; Schroeder DR; Martin DP; Sprung J
Surgery; 2017 Dec; 162(6):1259-1269. PubMed ID: 28919049
[TBL] [Abstract][Full Text] [Related]
16. Familial pheochromocytomas and paragangliomas: stories from the sign-out room.
Perren A; Komminoth P
Endocr Pathol; 2006; 17(4):337-44. PubMed ID: 17525482
[TBL] [Abstract][Full Text] [Related]
17. Molecular genetic alterations in adrenal and extra-adrenal pheochromocytomas and paragangliomas.
Dannenberg H; Komminoth P; Dinjens WN; Speel EJ; de Krijger RR
Endocr Pathol; 2003; 14(4):329-50. PubMed ID: 14739490
[TBL] [Abstract][Full Text] [Related]
18. Bilateral pheochromocytomas and congenital anomalies associated with a de novo germline mutation in the von Hippel-Lindau gene.
Assadi F; Brackbill EL
Am J Kidney Dis; 2003 Jan; 41(1):E3. PubMed ID: 12500216
[TBL] [Abstract][Full Text] [Related]
19. Somatic VHL gene deletion and point mutation in MEN 2A-associated pheochromocytoma.
Koch CA; Huang SC; Zhuang Z; Stolle C; Azumi N; Chrousos GP; Vortmeyer AO; Pacak K
Oncogene; 2002 Jan; 21(3):479-82. PubMed ID: 11821960
[TBL] [Abstract][Full Text] [Related]
20. Selective loss of chromosome 11 in pheochromocytomas associated with the VHL syndrome.
Lui WO; Chen J; Gläsker S; Bender BU; Madura C; Khoo SK; Kort E; Larsson C; Neumann HP; Teh BT
Oncogene; 2002 Feb; 21(7):1117-22. PubMed ID: 11850829
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
